Blanca I. Restrepo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Blanca I. Restrepo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Joseph B. McCormick
Division of Epidemiology, University of Texas School of Public Health, Brownsville, 80 Fort Brown, Brownsville, Texas 78520
3 shared publicationsMohammad H. Rahbar
Department of Epidemiology, B-644 West Fee Hall, College of Human Medicine, Michigan State University, East Lansing, MI 48824
2 shared publicationsPaula A. Pino
Division of Epidemiology, University of Texas Health Science Center at Houston, School of Public Health in Brownsville , Brownsville
2 shared publicationsSusan P. Fisher-Hoch
Division of Epidemiology, University of Texas School of Public Health, Brownsville, 80 Fort Brown, Brownsville, Texas 78520
2 shared publicationsAdrian Salinas
Division of Epidemiology, University of Texas Health Science Center at Houston, School of Public Health in Brownsville , Brownsville
1 shared publicationAndrés F. Franco
Universidad de Antioquia and Hospital Universitario San Vicente de Paul, Medellín, Colombia
1 shared publication
Latest Publications
- 1 October 2008
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 79 (4) , 541-544
Mycobacterial Clearance from Sputum Is Delayed during the First Phase of Treatment in Patients with Diabetes
Although type 2 diabetes (DM) is a recognized risk factor for development of tuberculosis (TB), the impact on treatment is unclear. Among the few published reports, some suggest that mycobacterial clearance during treatment is delayed in TB patients with DM. Using survival analysis on data from 469 culture-positive TB patients retrospectively identified in south Texas, we found DM to be an independent risk factor for a 5-day delay in mycobacterial clearance within the first 60 days of treatment.
- 1 October 2008
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 79 (4) , 541-544
Mycobacterial Clearance from Sputum Is Delayed during the First Phase of Treatment in Patients with Diabetes
Although type 2 diabetes (DM) is a recognized risk factor for development of tuberculosis (TB), the impact on treatment is unclear. Among the few published reports, some suggest that mycobacterial clearance during treatment is delayed in TB patients with DM. Using survival analysis on data from 469 culture-positive TB patients retrospectively identified in south Texas, we found DM to be an independent risk factor for a 5-day delay in mycobacterial clearance within the first 60 days of treatment.
- Open Access
- 1 September 2008
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (5) , 634-641
Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood Cells
Background. Although the biological basis for the increased susceptibility of diabetic patients to tuberculosis remains unclear, the world is undergo
- 1 September 2008
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (5) , 634-641
Open AccessTuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood Cells
Background. Although the biological basis for the increased susceptibility of diabetic patients to tuberculosis remains unclear, the world is undergo
- 16 April 2008
- Published by Wiley in Tropical Medicine & International Health
- Vol. 13 (5) , 653-658
Interpretation of mycobacterial antibodies in the cerebrospinal fluid of adults with tuberculous meningitis
Microbiological identification of Mycobacterium tuberculosis is insensitive and slow, and clinical distinction of tuberculous meningitis (TBM) from other subacute or chronic meningoenchephalitides (SACM) is difficult. Successful use of highly specific M. tuberculosis serological assays on cerebrospinal fluid has been reported, but their performance for diagnosis in a tuberculosis endemic country where they would be of most value is unclear. We sought to determine the biological basis for the uncertainty in interpretation of antibody detection in the CSF of TBM patients. We identified prospectively 46 adults with SACM and explored the concordance between TBM diagnosis and detection of highly specific M. tuberculosis antibodies in CSF. The source of antibodies in CSF was explored by evaluating the correlation between antibody titres in CSF with those in serum, or with the albumin quotient. Intrathecal IgG synthesis was assessed by the IgG index. Positive antibody titres were more frequent among TBM patients (76%), but were also present in individuals with other SACM (59%). A positive correlation between antibody titres in CSF with those in serum, or with the albumin quotient, supported the leakage of antibodies from plasma to CSF through an increased blood-brain barrier permeability. Intrathecal IgG synthesis was only detected in 35% of the TBM cases. Plasma antibodies likely synthesized in response to previous tuberculosis infections were a major source of mycobacterial antibodies in CSF due to leakage through an impaired blood-brain barrier. Interpretation of mycobacterial antibodies in CSF of adults for TBM, however specific, must take into account the contribution of antibodies from plasma, and hence, has questionable use for diagnosis.
- 16 April 2008
- Published by Wiley in Tropical Medicine & International Health
- Vol. 13 (5) , 653-658
Interpretation of mycobacterial antibodies in the cerebrospinal fluid of adults with tuberculous meningitis
Microbiological identification of Mycobacterium tuberculosis is insensitive and slow, and clinical distinction of tuberculous meningitis (TBM) from other subacute or chronic meningoenchephalitides (SACM) is difficult. Successful use of highly specific M. tuberculosis serological assays on cerebrospinal fluid has been reported, but their performance for diagnosis in a tuberculosis endemic country where they would be of most value is unclear. We sought to determine the biological basis for the uncertainty in interpretation of antibody detection in the CSF of TBM patients. We identified prospectively 46 adults with SACM and explored the concordance between TBM diagnosis and detection of highly specific M. tuberculosis antibodies in CSF. The source of antibodies in CSF was explored by evaluating the correlation between antibody titres in CSF with those in serum, or with the albumin quotient. Intrathecal IgG synthesis was assessed by the IgG index. Positive antibody titres were more frequent among TBM patients (76%), but were also present in individuals with other SACM (59%). A positive correlation between antibody titres in CSF with those in serum, or with the albumin quotient, supported the leakage of antibodies from plasma to CSF through an increased blood-brain barrier permeability. Intrathecal IgG synthesis was only detected in 35% of the TBM cases. Plasma antibodies likely synthesized in response to previous tuberculosis infections were a major source of mycobacterial antibodies in CSF due to leakage through an impaired blood-brain barrier. Interpretation of mycobacterial antibodies in CSF of adults for TBM, however specific, must take into account the contribution of antibodies from plasma, and hence, has questionable use for diagnosis.
- Open Access
- 15 August 2007
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (4) , 436-438
Convergence of the Tuberculosis and Diabetes Epidemics: Renewal of Old Acquaintances
Potential conflicts of interest.B.I.R.: no conflicts.
- 15 August 2007
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (4) , 436-438
Open AccessConvergence of the Tuberculosis and Diabetes Epidemics: Renewal of Old Acquaintances
Potential conflicts of interest.B.I.R.: no conflicts.
- 1 November 2006
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 67 (2) , 220-229
Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens
- 1 November 2006
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 67 (2) , 220-229
Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens